Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009405 · ClinicalTrials.gov registry record · NA
Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
A NA study of IV Infiltration and IV Extravasation, sponsored by Rhaeos.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07009405: Recruiting NA study of IV Infiltration and IV Extravasation, sponsored by Rhaeos.
NCT07009405 is a NA study of IV Infiltration and IV Extravasation that is actively recruiting participants, run by Rhaeos. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07009405, a NA study of IV Infiltration and IV Extravasation, is actively recruiting participants, sponsored by Rhaeos.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.
Primary Outcome
Exploratory assessment of thermal skin measurements taken with the study device
Conditions Studied
Interventions
- DEVICE non-invasive thermal infusion site monitoring NTISM device
Study Locations (1)
Illinois
- Infusacare - Skokie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT07009405 shows while recruiting
NCT07009405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with IV Infiltration appearing as the primary indexed condition, and to 1 intervention - of which non-invasive thermal infusion site monitoring NTISM device is the first listed.
NCT07009405 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07009405 about?
NCT07009405 is a clinical study titled "Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During". This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.
What is the current status of trial NCT07009405?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-05-28. Estimated completion is 2025-12.
What conditions does trial NCT07009405 study?
This clinical trial studies the following conditions: IV Infiltration, IV Extravasation.
What interventions are being tested in trial NCT07009405?
The interventions under investigation include: non-invasive thermal infusion site monitoring NTISM device (DEVICE).
Who is sponsoring clinical trial NCT07009405?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009405 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for IV Infiltration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07009405's enrollment target sits among peer trials
10 1928th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI